Palbik Pharma Private Limited
About Palbik Pharma Private Limited
Data last updated:
Palbik Pharma Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 03 November 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U51909JH2010PTC014481. Its GSTIN is 20AAFCP7330Q1Z8 (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Bikash Kumar Singh and Bhushan Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 521 Jharkhand X – Ray Gali Kanke Block Kanke, Ranchi, Jharkhand, India – 834006.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.33 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹10.16 Lakh (net margin 3%) and EBITDA of ₹17.64 Lakh (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹84.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Palbik Pharma Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 521 Jharkhand X – Ray Gali Kanke Block Kanke, Ranchi, Jharkhand, India – 834006
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Palbik Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Palbik Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Palbik Pharma Private Limited, buy the company report.
Financials of Palbik Pharma Private Limited
FY 2025 filings availablePalbik Pharma Private Limited reported revenue of ₹3.33 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 21% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Palbik Pharma Private Limited, buy the company report.
Board of directors of Palbik Pharma Private Limited
Palbik Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bikash Kumar Singh | Director | 03 Nov 2010 | 15 Years 11 Months | Current |
| Bhushan Sahay | Director | 29 Jun 2017 | 9 Years 3 Months | Current |
| Gopal Nand Jha | Director | 03 Nov 2010 | 15 Years 11 Months | Current |
Peer comparison
Palbik Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Accosts Remedies Private Limited | ₹3.34 Cr (FY 2025) | 1.0% | Uttar Pradesh, India | |||
| Wunderz Pharmaceuticals Private Limited | ₹3.33 Cr (FY 2024) | -2.0% | Kochi, Kerala, India | |||
| Hyeto Pharmaceuticals Private Limited | ₹3.33 Cr (FY 2025) | 2163.0% | Ranchi, Jharkhand, India | |||
| Palbik Pharma Private Limitedthis company | ₹3.33 Cr (FY 2025) | ₹10.16 Lakh | 3% | 21.0% | Ranchi, Jharkhand, India | |
| Acela Healthcare Private Limited | ₹3.33 Cr (FY 2025) | -8.0% | Ahmedabad, Gujarat, India | |||
| Rapid Biopharma Private Limited | ₹3.33 Cr (FY 2025) | 9.0% | Bangalore, Karnataka, India | |||
| Caryota Lifesciences India Private Limited | ₹3.33 Cr (FY 2025) | 9.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Palbik Pharma Private Limited, buy the company report.
Auditor
Palbik Pharma Private Limited is audited by PARIK & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARIK & CO | FY 2020 | 302147E |
Shareholding
The shareholding of Palbik Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Palbik Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2025 | 101112725 | Others | ₹55 Lakh | Open | |
| 15 Mar 2016 | 10627108 | State Bank of India | ₹10 Lakh | Open | |
| 20 Nov 2015 | 10607081 | State Bank of India | ₹12.5 Lakh | Open | |
| 22 Jan 2015 | 10547437 | Union Bank | ₹7 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Palbik Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Palbik Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Palbik Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAFCP7330Q1Z8 | Jharkhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Palbik Pharma Private Limited, buy the company report.
Recent activity
Palbik Pharma Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Bhushan Sahay was appointed as Director on 29 Jun 2017.
Frequently asked questions
Palbik Pharma is an active private limited company based in Ranchi, Jharkhand, India. The company works in wholesale, within the trading industry. It was incorporated on 03 November 2010 (16+ years old) and is registered under CIN U51909JH2010PTC014481.
Palbik Pharma has 3 current directors:
- Bikash Kumar Singh - Director
- Bhushan Sahay - Director
- Gopal Nand Jha - Director
The latest financial statements of Palbik Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Palbik Pharma is 20AAFCP7330Q1Z8, registered in Jharkhand.
The CIN (Corporate Identification Number) of Palbik Pharma is U51909JH2010PTC014481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Palbik Pharma was incorporated on 03 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Palbik Pharma by revenue are Accosts Remedies Private Limited, Wunderz Pharmaceuticals Private Limited, Hyeto Pharmaceuticals Private Limited, Acela Healthcare Private Limited, Rapid Biopharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Bhushan Sahay was appointed as Director on 29 Jun 2017. Bikash Kumar Singh was appointed as Director on 03 Nov 2010. Gopal Nand Jha was appointed as Director on 03 Nov 2010.
The registered office of Palbik Pharma is at Plot No. 521 Jharkhand X – Ray Gali Kanke Block Kanke, Ranchi, Jharkhand, India – 834006.
Palbik Pharma operates in the trading industry, in the wholesale segment.
Palbik Pharma has open charges of ₹84.5 Lakh and no satisfied charges on record as per latest MCA filings.